acetyl-seryl-leucyl-valine

Also Known As:

Ac-SLV; Acetyl-Ser-Leu-Val

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

1.	Colonic Neoplasms (Colon Cancer) 03/28/1997 - "Furthermore, the direct cytoplasmic microinjection of this tripeptide (Ac-SLV) resulted in the induction of Fas-mediated apoptosis in a colon cancer cell line that expresses both Fas and FAP-1. " 01/01/1997 - "Microinjection of the tri peptide (Ac SLV) could induce Fas-mediated apoptosis in the DLD 1 human colon cancer cell line that was resistant to anti-Fas-antibody. "
2.	Carcinoma (Carcinomatosis) 11/01/2004 - "In vitro, colon carcinoma cells were primarily cultured, and their sensitivity to Fas-mediated apoptosis was evaluated by treatment with agonistic anti-FasR CH11 IgM monoclonal antibody in the presence or absence of synthetic Ac-SLV (serine-leucine-valine) tripeptide. "